• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Practice Management Software Tebra Secures $72M

Share:

July 12, 2022

Practice management software company Tebra secured more than $72 million in equity and debt financing from Golub Capital, boosting its valuation to over $1 billion.

WHAT IT DOES

Tebra is the result of a recent merger between Kareo, which offers clinical and financial software, and PatientPop, which provides tools for patient engagement and practice growth. The deal closed in November.

The combined company includes products for building a medical practice’s website and advertising its services, online scheduling and patient reminders, telehealth, an EHR, billing, and payment, as well as data analytics.

Tebra will use the capital to accelerate its post-merger plans, like growing market share, developing and launching products as a combined company, and branding the new entity.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“With this new investment from Golub Capital, we’ll be able to accelerate Tebra’s mission to unlock better healthcare by helping independent practices bring modernized care to patients everywhere,” CEO and co-founder Dan Rodrigues said in a statement.

“Simultaneously, we will broaden our market reach and launch new solutions, helping an even larger number of physicians with digital tools and support to attract new patients, get paid quicker, and operate their practice more efficiently.”

MARKET SNAPSHOT

PatientPop raised $50 million in Series C funding in 2020 and $25 million in 2018. According to Crunchbase, Kareo last raised nearly $10 million in 2018. It also acquired billing-automation company PatientlySpeaking last year and patient-communications tool DoctorBase in 2015.

Another company in the practice management space, NexHealth, announced it had wrapped up a $125 million Series C funding round in April, bringing the company to a $1 billion valuation. It offers tools for online scheduling, marketing, and patient engagement.

Patient communication platform Luma Health scored $130 million late last year. Change Healthcare recently unveiled a new suite of engagement tools that were designed in collaboration with Luma.

Meanwhile, SocialClimb, which is focused on marketing medical practices, announced a $12 million raise early last year.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CRH Medical Corporation Announces Completion of Majority Acquisition of Coastal Carolina Sedation Associates, LLCCRH Medical Corporation Announces Completion of Majority Acquisition of Coastal Carolina Sedation Associates, LLC
  • Sleeping Pills (Prescription Drugs) Market To See Huge Growth By 2027Sleeping Pills (Prescription Drugs) Market To See Huge Growth By 2027
  • Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth PlatformLemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform
  • Turbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug DiscoveryTurbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug Discovery
  • Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood TestIllumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
  • Fintech And Biotech Are Coming Together To Transform Drug DevelopmentFintech And Biotech Are Coming Together To Transform Drug Development
  • Merit Medical puts $60m on the table for Vascular InsightsMerit Medical puts $60m on the table for Vascular Insights
  • Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Pennsylvania to Advance AAV Gene Therapy TechnologyFortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Pennsylvania to Advance AAV Gene Therapy Technology

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications